GoF ryanodine receptor 2 (RYR2) variants have been linked to CPVT, while LoF RYR2 variants have been linked to CRDS (Calcium Release Deficiency Syndrome) (Figure 1B). Here, RYR2 is linked to catecholaminergic polymorphic ventricular tachycardia.